Peritoneal dialysis and hemodialysis in systemic lupus erythematosus patients: comparison of clinical outcomes

Kidney Blood Press Res. 2009;32(6):451-6. doi: 10.1159/000266480. Epub 2009 Dec 17.

Abstract

Background: This study compared peritoneal dialysis (PD) and hemodialysis (HD) outcomes between female systemic lupus erythematosus (SLE) patients with end-stage renal disease (ESRD) due to lupus nephropathy.

Methods: 22 female SLE patients undergoing PD were compared with 14 female SLE patients receiving HD. Clinical outcomes and infective complications were reviewed.

Results: The overall mortality rate was much higher in the PD group (6/22) than in the HD group (1/14) (p = 0.027). PD patients had higher C-reactive protein level (37.1 +/- 41.4 vs. 6.7 +/- 9.5 mg/l, p = 0.037) and numbers of infectious episode (PD vs. HD: 1 episode per 33.16 patient-months vs. 1 episode per 118.26 patient-months, respectively, p = 0.046). Before the end of the observation period, HD patients had higher serum albumin (3.8 +/- 0.2 vs. 3.3 +/- 0.6 g/dl, p = 0.01).

Conclusions: In female SLE patients with ESRD due to lupus nephropathy, clinical outcomes are better after undergoing HD than after undergoing PD.

Publication types

  • Comparative Study

MeSH terms

  • Adult
  • C-Reactive Protein / metabolism
  • Cause of Death
  • Female
  • Humans
  • Immunosuppressive Agents / therapeutic use
  • Infections / complications
  • Kaplan-Meier Estimate
  • Kidney Failure, Chronic / etiology
  • Kidney Failure, Chronic / therapy*
  • Lupus Erythematosus, Systemic / complications
  • Lupus Erythematosus, Systemic / therapy*
  • Male
  • Middle Aged
  • Peritoneal Dialysis*
  • Renal Dialysis*
  • Retrospective Studies
  • Serum Albumin / metabolism
  • Survival Analysis
  • Treatment Outcome

Substances

  • Immunosuppressive Agents
  • Serum Albumin
  • C-Reactive Protein